280 results
POS AM
GOVX
Geovax Labs Inc
1 Mar 24
Prospectus update (post-effective amendment)
4:04pm
regulation. In order to sell our products in the United States, approval from the U.S. Food and Drug Administration (the “FDA”) is required. Satisfaction … and the satisfaction of liabilities in the normal course of business for the twelve-month period following the issue date of these financial statements
POS AM
GOVX
Geovax Labs Inc
1 Mar 24
Prospectus update (post-effective amendment)
4:04pm
our products in the United States, approval from the U.S. Food and Drug Administration (the “FDA”) is required. Satisfaction of regulatory requirements … statements have been prepared assuming that we will continue as a going concern, which contemplates realization of assets and the satisfaction
POS AM
43jfv7b
1 Mar 24
Prospectus update (post-effective amendment)
4:03pm
POS AM
yvzl8
1 Mar 24
Prospectus update (post-effective amendment)
4:03pm
424B3
joyqkq
12 Jan 24
Prospectus supplement
4:00pm
8-K
EX-10.1
dc22t3atd 7f7i948
4 Dec 23
Entry into a Material Definitive Agreement
8:00am
8-K
EX-4.1
r5tfxjvuh9h2
4 Dec 23
Entry into a Material Definitive Agreement
8:00am
8-K
lmz2a 28e0
4 Dec 23
Entry into a Material Definitive Agreement
8:00am
424B3
ggvvj
8 Nov 23
Prospectus supplement
4:04pm
424B3
1yhe4eynr 1slyh
8 Nov 23
Prospectus supplement
4:03pm
424B3
4805csixga el9j8y
8 Nov 23
Prospectus supplement
4:01pm
S-8
EX-5.1
t73u9 hw9pftj8
22 Aug 23
Registration of securities for employees
4:06pm
S-8
EX-99.1
ria3jn6p
22 Aug 23
Registration of securities for employees
4:06pm